Metropolitan Life Insurance Co. NY maintained its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the first quarter, Holdings Channel reports. The institutional investor owned 8,574 shares of the company’s stock at the end of the first quarter. Metropolitan Life Insurance Co. NY’s holdings in U.S. Physical Therapy were worth $560,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Wells Fargo & Company MN raised its position in shares of U.S. Physical Therapy by 5.5% in the first quarter. Wells Fargo & Company MN now owns 44,458 shares of the company’s stock valued at $2,903,000 after buying an additional 2,335 shares in the last quarter. Legato Capital Management LLC raised its position in shares of U.S. Physical Therapy by 6,430.0% in the first quarter. Legato Capital Management LLC now owns 95,534 shares of the company’s stock worth $1,463,000 after buying an additional 94,071 shares during the period. Oxford Asset Management acquired a new position in shares of U.S. Physical Therapy during the first quarter worth about $1,321,000. Oppenheimer Asset Management Inc. acquired a new position in shares of U.S. Physical Therapy during the first quarter worth about $221,000. Finally, Sawgrass Asset Management LLC acquired a new position in shares of U.S. Physical Therapy during the first quarter worth about $345,000. Institutional investors own 96.10% of the company’s stock.

Shares of U.S. Physical Therapy, Inc. (USPH) traded down 0.16% during trading on Thursday, hitting $62.95. 15,036 shares of the stock were exchanged. The stock has a market cap of $791.97 million, a PE ratio of 39.84 and a beta of 1.06. U.S. Physical Therapy, Inc. has a one year low of $51.96 and a one year high of $78.00. The stock’s 50 day moving average price is $62.60 and its 200 day moving average price is $66.14.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.60 by $0.01. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. The firm had revenue of $104.25 million during the quarter, compared to the consensus estimate of $102.93 million. Equities research analysts predict that U.S. Physical Therapy, Inc. will post $2.13 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Monday, August 21st will be issued a $0.20 dividend. The ex-dividend date is Thursday, August 17th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.27%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 46.78%.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/metropolitan-life-insurance-co-ny-maintains-stake-in-u-s-physical-therapy-inc-usph/1470900.html.

A number of equities analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Thursday, June 8th. Jefferies Group LLC set a $65.00 target price on shares of U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, August 4th. Cantor Fitzgerald assumed coverage on shares of U.S. Physical Therapy in a research report on Monday, July 24th. They set an “overweight” rating and a $72.00 target price on the stock. Finally, BidaskClub lowered shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company’s stock. U.S. Physical Therapy presently has an average rating of “Hold” and an average price target of $68.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.